chloromethyl cyclohexylmethyl ether | 1625-60-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: chloromethyl cyclohexylmethyl ether
• 英文别名: ((Chloromethoxy)methyl)cyclohexane；chloromethoxymethylcyclohexane
• CAS: 1625-60-1
• 化学式: C₈H₁₅ClO
• 分子量: 162.66
• InChiKey: QZZVDGKPSLFMGA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  chloromethyl cyclohexylmethyl ether 在 硫酸氢铵 、 氯磺酰异氰酸酯 、 六甲基二硅氮烷 、 lithium diisopropyl amide 作用下， 反应 19.0h， 生成 1-[(环己基甲氧基)甲基]-5-乙基-6-(苯基硫烷基)-2-硫代-2,3-二氢嘧啶-4(1H)-酮
  参考文献：
  名称：

  1-[（（2-羟基乙氧基）甲基] -6-（苯硫基）胸腺嘧啶（HEPT）的脱氧类似物的合成及其抗病毒活性，可作为有效的和选择性的抗HIV-1药物。

  摘要：

  通过合成一系列脱氧类似物和相关化合物，研究了1-[（（2-羟基乙氧基）甲基] -6-（苯硫基）-胸腺嘧啶（HEPT）的无环结构中的取代对抗HIV-1活性的影响。基于HEPT与伯烷基卤化物的烷基化，进行1-[（（2-烷氧基乙氧基）甲基] -6-（苯硫基）胸腺嘧啶（2-4）衍生物的制备。进行了1-[（（烷氧基）甲基] -6-（苯硫基）胸腺嘧啶（26-31）和1-[（（烷氧基）甲基] -6-（芳硫基）-2-硫尿嘧啶（32-45）衍生物的制备根据LDA对1-[（（烷氧基）-甲基]胸腺嘧啶（9-14）和1-[（（烷氧基）甲基] -2-硫氧嘧啶（15-25）进行锂化反应，然后与二芳基二硫化物反应。2-硫尿嘧啶衍生物的氧化水解得到1-[（（烷氧基）甲基] -6-（芳硫基）尿嘧啶衍生物（46-57）。1-烷基-6-（苯硫基）胸腺嘧啶（59-61）衍生物是基于6-（苯硫基）胸腺嘧啶（58）的烷基化制备的。H

  DOI：

  10.1021/jm00103a009

文献信息

• TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED FROM THE SAME
  申请人：Yoshitomo Akira

  公开号：US20110172457A1

  公开（公告）日：2011-07-14

  Disclosed are tetrakis(ether-substituted formylphenyl) expressed by General Formula (1), as well as polynuclear polyphenol derived from such tetrakis(ether-substituted formylphenyl): (In the formula, R 1 represents an alkyl group with 1 to 8 carbon atoms or alkoxyl group with 1 to 8 carbon atoms, or aromatic hydrocarbon group or saturated hydrocarbon group with 1 to 8 carbon atoms having an aromatic hydrocarbon group, n represents 0 or an integer of 1 to 3, R 2 represents a divalent monocyclic or fused-ring aromatic hydrocarbon group with 6 to 15 carbon atoms or divalent aliphatic hydrocarbon group with 1 to 8 carbon atoms that may have a monocyclic or fused-ring aromatic hydrocarbon group with 6 to 15 carbon atoms, R 3 represents a hydrogen atom or alkyl group with 1 to 6 carbon atoms, A represents a tetravalent carbon atom group or tetravalent saturated hydrocarbon group with 2 or more carbon atoms, where, if A is a tetravalent saturated hydrocarbon group with 2 or more carbon atoms, the two carbon atoms in the A group are bonded with two phenyl groups, respectively.)

  通用公式（1）表示的四（醚取代甲酰基苯基）以及由此类四（醚取代甲酰基苯基）衍生的多核多酚已公开：（在公式中，R1代表具有1至8个碳原子的烷基基团或具有1至8个碳原子的烷氧基团，或具有具有芳香烃基的1至8个碳原子的芳香烃基或饱和碳氢基团，n代表0或1至3的整数，R2代表具有6至15个碳原子的二价单环或融合环芳香烃基团或具有1至8个碳原子的二价脂肪碳氢基团，该基团可能具有具有6至15个碳原子的单环或融合环芳香烃基团，R3代表氢原子或具有1至6个碳原子的烷基基团，A代表四价碳原子基团或具有2个或更多碳原子的四价饱和碳氢基团，如果A是具有2个或更多碳原子的四价饱和碳氢基团，则A基团中的两个碳原子分别与两个苯基团结合。）
• SALT, PHOTORESIST COMPOSITION, AND METHOD FOR PRODUCING PHOTORESIST PATTERN
  申请人：ICHIKAWA Koji

  公开号：US20120264060A1

  公开（公告）日：2012-10-18

  A salt represented by formula (I): wherein Q 1 and Q 2 independently each represent a fluorine atom or a C1-C6 perfluoroalkyl group, L 1 represents a C1-C17 divalent saturated hydrocarbon group in which a methylene group may be replaced by an oxygen atom or a carbonyl group, L 2 and L 3 respectively represent a single bond or a C1-C6 divalent saturated alkyl group in which a methylene group may be replaced by an oxygen atom or a carbonyl group, ring W 1 and ring W 2 respectively represent a C3-C36 hydrocarbon ring, R 1 and R 2 respectively represent a hydrogen atom or C1-C6 alkyl group, R 3 represents C1-C6 alkyl group, t represents an integer of 0 to 2 and Z + represents an organic counter ion

  一种由化学式（I）表示的盐：其中Q1和Q2分别代表氟原子或C1-C6全氟烷基基团，L1代表C1-C17的二价饱和碳氢基团，其中一个亚甲基基团可被氧原子或羰基取代，L2和L3分别代表单键或C1-C6的二价饱和烷基基团，其中一个亚甲基基团可被氧原子或羰基取代，环W1和环W2分别代表C3-C36的碳氢环，R1和R2分别代表氢原子或C1-C6烷基基团，R3代表C1-C6烷基基团，t代表0到2之间的整数，Z+代表有机对离子。
• COMPOUND, RESIN, PHOTORESIST COMPOSITION, AND METHOD FOR PRODUCING PHOTORESIST PATTERN
  申请人：ICHIKAWA Koji

  公开号：US20120295201A1

  公开（公告）日：2012-11-22

  A compound represented by formula (I): wherein T 1 represents a single bond or a C6-C14 aromatic hydrocarbon group, L 1 represents a C1-C17 divalent saturated hydrocarbon group in which a methylene group may be replaced by an oxygen atom or a carbonyl group, L 2 and L 3 each independently represent a single bond or a C1-C6 divalent saturated hydrocarbon group in which a methylene group may be replaced by an oxygen atom or a carbonyl group, ring W 1 and ring W 2 each independently represent a C3-C36 hydrocarbon ring, R 1 and R 2 each independently represent a hydrogen atom, a hydroxyl group, or C1-C6 alkyl group, R 3 and R 4 each independently represent a hydroxyl group, or C1-C6 alkyl group, R 5 represents a hydroxyl group or a methyl group, m represents 0 or 1, and t and u each independently represent an integer of 0 to 2.

  一个由化学式(I)表示的化合物：其中T1代表一个单键或一个C6-C14芳香烃基，L1代表一个C1-C17二价饱和碳氢基团，其中一个亚甲基基团可以被氧原子或羰基所取代，L2和L3分别独立地代表一个单键或一个C1-C6二价饱和碳氢基团，其中一个亚甲基基团可以被氧原子或羰基所取代，环W1和环W2分别独立地代表一个C3-C36碳氢环，R1和R2分别独立地代表一个氢原子、一个羟基或一个C1-C6烷基基团，R3和R4分别独立地代表一个羟基或一个C1-C6烷基基团，R5代表一个羟基或一个甲基基团，m代表0或1，t和u分别独立地代表0到2之间的整数。
• Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 2. Preparation and in vitro and in vivo evaluaton of 1-(alkoxymethyl)-2-[(hydroxyimino)methyl]-3-methylimidazolium halides for reactivation of organophosphorus-inhibited acetylcholinesterases
  作者：Clifford D. Bedford、Ralph N. Harris、Robert A. Howd、Dane A. Goff、Gary A. Koolpe、M. Petesch、Alexi Miller、Harold W. Nolen、H. A. Musallam

  DOI：10.1021/jm00122a034

  日期：1989.2

  A series of structurally related mono- and bis-1,3-disubstituted 2-[(hydroxyimino)methyl]imidazolium halides were evaluated in vitro for their ability to reactivate electric eel, bovine, and human erythrocyte (RBC) acetylcholinesterases (AChE) inhibited by ethyl p-nitrophenyl methylphosphonate (EPMP) and 3,3-dimethyl-2-butyl methyl-phosphonofluoridate (soman, GD). All new compounds were characterized for (hydroxyimino)methyl acid dissociation constant, nucleophilicity, octanol-buffer partition coefficient, reversible AChE inhibition, and kinetics of reactivation of EPMP-inhibited AChEs. For GD-inhibited AChEs, maximal reactivation was used to compare compounds since rapid phosphonyl enzyme dealkylation "aging" complicated interpretation of kinetic constants. For comparison, we also evaluated three known pyridinium therapeutics, 2-PAM, HI-6, and toxogonin. In vivo evaluation in mice revealed that when selected imidazolium compounds were coadministered with atropine sulfate, they were effective in providing lifesaving protection against both GD and EPMP challenges. This was a major accomplishment in the search for effective anticholinesterase therapeutics--the synthesis and preliminary evaluation of the first new monoquaternary soman antidotes with potencies superior to 2-PAM. Significantly, there was an apparent inverse relationship between in vitro and in vivo results; the most potent in vivo compounds proved to be the poorest in vitro reactivators. These results suggested that an alternative and possibly novel antidotal mechanism of protective action may be applicable for the imidazolium aldoximes. Selected compounds were also evaluated for their inhibition of AChE phosphorylation by GD and antimuscarinic and antinicotinic receptor blocking effects.
• Antimicrobial activities of new analogues of benzalkonium chloride
  作者：J Pernak

  DOI：10.1016/s0223-5234(99)00216-0

  日期：1999.9